Pharmacy News Articles

▼ Show details

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Effect of reiki therapy on pain and anxiety in adults: an in-depth literature review of randomized trials with effect size calculations Pain Management Nursing, October 2, 2014    Clinical Article

2 Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients The Breast, October 2, 2014    Clinical Article

3 Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis Neonatology, October 2, 2014    Evidence Based Medicine    Review Article

4 Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence Drugs, October 2, 2014    Clinical Article

5 Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder Pediatrics, October 2, 2014    Clinical Article

6 Placebo use in pain management: the role of medical context, treatment efficacy, and deception in determining placebo acceptability Pain, October 2, 2014

7 The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea Clinical Infectious Diseases, October 2, 2014    Clinical Article

8 Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis Clinical Gastroenterology and Hepatology , October 2, 2014    Clinical Article

9 Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 JAMA Internal Medicine, October 2, 2014    Clinical Article

10 Preemptive analgesia with bupivacaine in reduction mammaplasty: a prospective, randomized, double-blind, placebo-controlled trial Plastic and Reconstructive Surgery, October 2, 2014    Clinical Article

11 Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: A 24-week prospective right–left comparative clinical trial Journal of the European Academy of Dermatology and Venereology, October 2, 2014    Clinical Article

12 Clinical observation of fire-needle therapy plus tuina for senile knee osteoarthritis Journal of Acupuncture and Tuina Science, October 2, 2014    Clinical Article
Exclusive Author Commentary

13 Latanoprost in the treatment of glaucoma Full Text Clinical Ophthalmology, October 2, 2014    Review Article

14 Quality indicators to measure appropriate antibiotic use in hospitalized adults Clinical Infectious Diseases, October 2, 2014    Clinical Article

15 A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial The Breast, October 2, 2014    Clinical Article

16 Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops Drug Metabolism and Disposition, October 2, 2014    Clinical Article

17 Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells Drug Metabolism and Disposition, October 2, 2014    Clinical Article

18 Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens Full Text Clinical Pharmacology: Advances and Applications, October 2, 2014    Review Article

19 Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): An open-label, randomised, multicentre, phase 2 study The Lancet Oncology, October 2, 2014    Clinical Article

20 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): A double-blind, randomised phase 3 trial The Lancet Oncology, October 2, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close